Management of Triple-Negative Breast Cancer
Systemic Therapy Recommendations
- The National Comprehensive Cancer Network recommends that tumors ≥2cm in diameter warrant adjuvant chemotherapy, even in node-negative disease, as this represents a high-risk feature in triple-negative breast cancer 1, 2, 3, 4, 5, 6, 7.
Radiation Therapy Considerations
- The National Comprehensive Cancer Network suggests that post-mastectomy radiation is generally not recommended for node-negative tumors <5cm with clear margins (≥1mm) 1, 2, 3.
- The National Comprehensive Cancer Network recommends considering post-mastectomy radiation for high-risk features, including close margins (<1mm) 1, 2, 3, tumors ≥2cm 1, 2, 4, 5, 6, 7, premenopausal status 1, 2, 4, 5, 6, 7, lymphovascular invasion 1, 2, 4, 5, 6, 7, and triple-negative subtype specifically 1, 2, 4, 5, 6, 7.
- The National Comprehensive Cancer Network recommends considering radiation therapy after breast-conserving surgery for TNBC management, as TNBC shows increased risk of locoregional recurrence even with tumors ≤5cm 1, 2, 4, 5, 6, 7.
Critical Pitfalls to Avoid
- The National Comprehensive Cancer Network advises against undertreating based solely on node-negative status, as triple-negative biology and tumor size ≥2cm are independent high-risk features 1, 2, 3.
- The National Comprehensive Cancer Network recommends considering radiation therapy, as TNBC has higher locoregional recurrence rates than other subtypes 1, 2.